LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,254,389 | -49.4% | 1,150,817 | +6.4% | 0.00% | – |
| Q2 2023 | $2,477,393 | +33.6% | 1,081,831 | +41.7% | 0.00% | – |
| Q1 2023 | $1,854,732 | +23.4% | 763,264 | -3.0% | 0.00% | – |
| Q4 2022 | $1,503,115 | -14.8% | 786,971 | +7.0% | 0.00% | – |
| Q3 2022 | $1,765,000 | +41.0% | 735,510 | +9.4% | 0.00% | – |
| Q2 2022 | $1,252,000 | -9.3% | 672,463 | +1.8% | 0.00% | – |
| Q1 2022 | $1,380,000 | -49.1% | 660,406 | -4.1% | 0.00% | – |
| Q4 2021 | $2,713,000 | -18.0% | 688,376 | +0.0% | 0.00% | -100.0% |
| Q3 2021 | $3,309,000 | -1.0% | 688,078 | -5.5% | 0.00% | 0.0% |
| Q2 2021 | $3,341,000 | -4.5% | 727,996 | +22.1% | 0.00% | 0.0% |
| Q1 2021 | $3,499,000 | +89.4% | 596,231 | +10.5% | 0.00% | – |
| Q4 2020 | $1,847,000 | +138.0% | 539,795 | +0.2% | 0.00% | – |
| Q3 2020 | $776,000 | -30.5% | 538,945 | -3.6% | 0.00% | – |
| Q2 2020 | $1,116,000 | -1.6% | 559,151 | -3.9% | 0.00% | – |
| Q1 2020 | $1,134,000 | -48.8% | 581,549 | +9.0% | 0.00% | – |
| Q4 2019 | $2,214,000 | +40.3% | 533,543 | +1.7% | 0.00% | – |
| Q3 2019 | $1,578,000 | -54.8% | 524,441 | -5.6% | 0.00% | -100.0% |
| Q2 2019 | $3,494,000 | +5.8% | 555,530 | -6.4% | 0.00% | 0.0% |
| Q1 2019 | $3,302,000 | -17.9% | 593,832 | -2.0% | 0.00% | 0.0% |
| Q4 2018 | $4,024,000 | -39.0% | 605,764 | -2.0% | 0.00% | -50.0% |
| Q3 2018 | $6,597,000 | -5.9% | 618,243 | +5.8% | 0.00% | 0.0% |
| Q2 2018 | $7,013,000 | +43.1% | 584,393 | +2.1% | 0.00% | +100.0% |
| Q1 2018 | $4,902,000 | -16.2% | 572,104 | -3.4% | 0.00% | 0.0% |
| Q4 2017 | $5,852,000 | -20.6% | 592,309 | -1.3% | 0.00% | -50.0% |
| Q3 2017 | $7,374,000 | -27.1% | 599,890 | -2.4% | 0.00% | -33.3% |
| Q2 2017 | $10,109,000 | +18.5% | 614,533 | +3.3% | 0.00% | +50.0% |
| Q1 2017 | $8,532,000 | +5.5% | 595,008 | +1.7% | 0.00% | 0.0% |
| Q4 2016 | $8,090,000 | -20.8% | 584,968 | +3.5% | 0.00% | -33.3% |
| Q3 2016 | $10,214,000 | +32.8% | 565,318 | +5.5% | 0.00% | +50.0% |
| Q2 2016 | $7,689,000 | +33.0% | 535,788 | +10.7% | 0.00% | 0.0% |
| Q1 2016 | $5,783,000 | -8.5% | 483,946 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $6,321,000 | +27.2% | 474,916 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $4,968,000 | +54.6% | 462,527 | +15.8% | 0.00% | +100.0% |
| Q2 2015 | $3,214,000 | – | 399,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |